Teza Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-66,468
Closed -$2.8M 810
2023
Q2
$2.8M Buy
+66,468
New +$2.69M 0.45% 58
2023
Q1
Sell
-15,472
Closed -$568K 757
2022
Q4
$568K Buy
15,472
+8,251
+114% +$326K 0.11% 299
2022
Q3
$340K Buy
+7,221
New +$466K 0.07% 389
2021
Q3
Sell
-6,186
Closed -$554K 645
2021
Q2
$554K Buy
6,186
+1,026
+20% +$86.7K 0.09% 292
2021
Q1
$391K Buy
+5,160
New +$389K 0.08% 325
2019
Q4
Sell
-3,827
Closed -$204K 771
2019
Q3
$204K Buy
+3,827
New +$196K 0.05% 450

Other funds holding SYNH

Teza Capital Management's SYNH Position: Q3 2023 in Review

Teza Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 66,468 shares — an estimated $2.8M sold.

Teza Capital Management first reported a position in SYNH in Q3 2019 and held it in 6 quarters. The position peaked at $2.8M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Teza Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Teza Capital Management sold 66,468 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.8M.
  • Teza Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 6 quarters.
  • Teza Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $2.8M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Teza Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.